These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 38421180)
1. The SARS-CoV-2 Spike is a virulence determinant and plays a major role on the attenuated phenotype of Omicron virus in a feline model of infection. Martins M; Nooruzzaman M; Cunningham JL; Ye C; Caserta LC; Jackson N; Martinez-Sobrido L; Fang Y; Diel DG J Virol; 2024 Mar; 98(3):e0190223. PubMed ID: 38421180 [TBL] [Abstract][Full Text] [Related]
2. The Omicron Variant BA.1.1 Presents a Lower Pathogenicity than B.1 D614G and Delta Variants in a Feline Model of SARS-CoV-2 Infection. Martins M; do Nascimento GM; Nooruzzaman M; Yuan F; Chen C; Caserta LC; Miller AD; Whittaker GR; Fang Y; Diel DG J Virol; 2022 Sep; 96(17):e0096122. PubMed ID: 36000850 [TBL] [Abstract][Full Text] [Related]
3. The Omicron variant BA.1.1 presents a lower pathogenicity than B.1 D614G and Delta variants in a feline model of SARS-CoV-2 infection. Martins M; do Nascimento GM; Nooruzzaman M; Yuan F; Chen C; Caserta LC; Miller AD; Whittaker GR; Fang Y; Diel DG bioRxiv; 2022 Jun; ():. PubMed ID: 35734088 [TBL] [Abstract][Full Text] [Related]
5. Adaptive variations in SARS-CoV-2 spike proteins: effects on distinct virus-cell entry stages. Qing E; Gallagher T mBio; 2023 Aug; 14(4):e0017123. PubMed ID: 37382441 [TBL] [Abstract][Full Text] [Related]
6. Characterization of Entry Pathways, Species-Specific Angiotensin-Converting Enzyme 2 Residues Determining Entry, and Antibody Neutralization Evasion of Omicron BA.1, BA.1.1, BA.2, and BA.3 Variants. Neerukonda SN; Wang R; Vassell R; Baha H; Lusvarghi S; Liu S; Wang T; Weiss CD; Wang W J Virol; 2022 Sep; 96(17):e0114022. PubMed ID: 36000843 [TBL] [Abstract][Full Text] [Related]
7. Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant. Suzuki R; Yamasoba D; Kimura I; Wang L; Kishimoto M; Ito J; Morioka Y; Nao N; Nasser H; Uriu K; Kosugi Y; Tsuda M; Orba Y; Sasaki M; Shimizu R; Kawabata R; Yoshimatsu K; Asakura H; Nagashima M; Sadamasu K; Yoshimura K; ; Sawa H; Ikeda T; Irie T; Matsuno K; Tanaka S; Fukuhara T; Sato K Nature; 2022 Mar; 603(7902):700-705. PubMed ID: 35104835 [TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 strains bearing Omicron BA.1 spike replicate in C57BL/6 mice. Ogger PP; Martín MG; Jang S; Zhou J; Brown J; Sukhova K; Furnon W; Patel AH; Cowton V; Palmarini M; Barclay WS; Johansson C Front Immunol; 2024; 15():1383612. PubMed ID: 38742107 [TBL] [Abstract][Full Text] [Related]
9. The Spike-Stabilizing D614G Mutation Interacts with S1/S2 Cleavage Site Mutations To Promote the Infectious Potential of SARS-CoV-2 Variants. Gellenoncourt S; Saunders N; Robinot R; Auguste L; Rajah MM; Kervevan J; Jeger-Madiot R; Staropoli I; Planchais C; Mouquet H; Buchrieser J; Schwartz O; Chakrabarti LA J Virol; 2022 Oct; 96(19):e0130122. PubMed ID: 36121299 [TBL] [Abstract][Full Text] [Related]
10. Reduced Pathogenicity and Transmission Potential of Omicron BA.1 and BA.2 Sublineages Compared with the Early Severe Acute Respiratory Syndrome Coronavirus 2 D614G Variant in Syrian Hamsters. Su W; Choy KT; Gu H; Sia SF; Cheng KM; Nizami SIN; Krishnan P; Ng YM; Chang LDJ; Liu Y; Cheng SMS; Peiris M; Poon LLM; Nicholls JM; Yen HL J Infect Dis; 2023 May; 227(10):1143-1152. PubMed ID: 35776136 [TBL] [Abstract][Full Text] [Related]
11. Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity. Meng B; Abdullahi A; Ferreira IATM; Goonawardane N; Saito A; Kimura I; Yamasoba D; Gerber PP; Fatihi S; Rathore S; Zepeda SK; Papa G; Kemp SA; Ikeda T; Toyoda M; Tan TS; Kuramochi J; Mitsunaga S; Ueno T; Shirakawa K; Takaori-Kondo A; Brevini T; Mallery DL; Charles OJ; ; ; ; Bowen JE; Joshi A; Walls AC; Jackson L; Martin D; Smith KGC; Bradley J; Briggs JAG; Choi J; Madissoon E; Meyer KB; Mlcochova P; Ceron-Gutierrez L; Doffinger R; Teichmann SA; Fisher AJ; Pizzuto MS; de Marco A; Corti D; Hosmillo M; Lee JH; James LC; Thukral L; Veesler D; Sigal A; Sampaziotis F; Goodfellow IG; Matheson NJ; Sato K; Gupta RK Nature; 2022 Mar; 603(7902):706-714. PubMed ID: 35104837 [TBL] [Abstract][Full Text] [Related]
12. Spike mutations contributing to the altered entry preference of SARS-CoV-2 omicron BA.1 and BA.2. Hu B; Chan JF; Liu H; Liu Y; Chai Y; Shi J; Shuai H; Hou Y; Huang X; Yuen TT; Yoon C; Zhu T; Zhang J; Li W; Zhang AJ; Zhou J; Yuan S; Zhang BZ; Yuen KY; Chu H Emerg Microbes Infect; 2022 Dec; 11(1):2275-2287. PubMed ID: 36039901 [TBL] [Abstract][Full Text] [Related]
13. Intrinsic D614G and P681R/H mutations in SARS-CoV-2 VoCs Alpha, Delta, Omicron and viruses with D614G plus key signature mutations in spike protein alters fusogenicity and infectivity. Khatri R; Siddqui G; Sadhu S; Maithil V; Vishwakarma P; Lohiya B; Goswami A; Ahmed S; Awasthi A; Samal S Med Microbiol Immunol; 2023 Feb; 212(1):103-122. PubMed ID: 36583790 [TBL] [Abstract][Full Text] [Related]
14. Mutations in nonstructural proteins essential for pathogenicity in SARS-CoV-2-infected mice. Pan R; Li P; Meyerholz DK; Perlman S J Virol; 2024 Jul; 98(7):e0058424. PubMed ID: 38888344 [TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo differences in neurovirulence between D614G, Delta And Omicron BA.1 SARS-CoV-2 variants. Bauer L; Rissmann M; Benavides FFW; Leijten L; van Run P; Begeman L; Veldhuis Kroeze EJB; Lendemeijer B; Smeenk H; de Vrij FMS; Kushner SA; Koopmans MPG; Rockx B; van Riel D Acta Neuropathol Commun; 2022 Sep; 10(1):124. PubMed ID: 36058935 [TBL] [Abstract][Full Text] [Related]
16. Characterization of the SARS-CoV-2 BA.5.5 and BQ.1.1 Omicron variants in mice and hamsters. Case JB; Scheaffer SM; Darling TL; Bricker TL; Adams LJ; Harastani HH; Trende R; Sanapala S; Fremont DH; Boon ACM; Diamond MS J Virol; 2023 Sep; 97(9):e0062823. PubMed ID: 37676002 [TBL] [Abstract][Full Text] [Related]
17. Temperature-dependent Spike-ACE2 interaction of Omicron subvariants is associated with viral transmission. Benlarbi M; Ding S; Bélanger É; Tauzin A; Poujol R; Medjahed H; El Ferri O; Bo Y; Bourassa C; Hussin J; Fafard J; Pazgier M; Levade I; Abrams C; Côté M; Finzi A mBio; 2024 Aug; 15(8):e0090724. PubMed ID: 38953636 [TBL] [Abstract][Full Text] [Related]
18. The impact of S2 mutations on Omicron SARS-CoV-2 cell surface expression and fusogenicity. Escalera A; Laporte M; Turner S; Karakus U; Gonzalez-Reiche AS; van de Guchte A; Farrugia K; Khalil Z; van Bakel H; Smith D; García-Sastre A; Aydillo T Emerg Microbes Infect; 2024 Dec; 13(1):2297553. PubMed ID: 38112266 [TBL] [Abstract][Full Text] [Related]
19. Identification and Analysis of Monoclonal Antibodies with Neutralizing Activity against Diverse SARS-CoV-2 Variants. Ishimaru H; Nishimura M; Tjan LH; Sutandhio S; Marini MI; Effendi GB; Shigematsu H; Kato K; Hasegawa N; Aoki K; Kurahashi Y; Furukawa K; Shinohara M; Nakamura T; Arii J; Nagano T; Nakamura S; Sano S; Iwata S; Okamura S; Mori Y J Virol; 2023 Jun; 97(6):e0028623. PubMed ID: 37191569 [TBL] [Abstract][Full Text] [Related]